Professor of Paediatric Oncology and Late Effects
Adam Glaser is a Consultant Paediatric Oncologist and Late Effects physician at the Leeds Teaching Hospitals NHS Trust. He is a Professor of Paediatric Oncology and Late Effects at the University of Leeds.
Whilst working at the Department of Health as Clinical Director of the National Cancer Survivor Initiative (2010-13), he identified the dearth of robust evidence to support the introduction of sustainable services for the increasingly prevalent section of society living with and beyond cancer. Consequently, he led on the development of the National Cancer PROMs (Patient Reported Outcome Measures) Programme and successfully delivered the national colorectal cancer PROMs survey, the largest cancer PROMs exercise in the world to date.
A successful research programme in Leeds focusing on identification of the consequences of living with and beyond cancer has been established. He is currently principal, or co-principal, investigator on in excess of £5 million of research and teaching programmes. These include the Prostate Cancer UK/Movember Foundation funded Life After Prostate Cancer Diagnosis programme and the Yorkshire Cancer Research funded Life and Bladder Cancer. Personal and societal costs of cancer are being explored through the linkage of primary, secondary and tertiary health care records as part of a Macmillan Cancer Support funded programme CPR for Cancer Outcomes: The use of comprehensive patient records (CPR) to define the impact of cancer, co-morbidities and late-effects on individuals and the health service. An innovative clinical research training fellowship programme funded by Candlelighters has been established to allow paediatric oncologists in training to obtain high quality research exposure.